tiprankstipranks
pc:nilot

Nilo Therapeutics

Nilo Therapeutics is a biotechnology company focused on developing innovative medicines that leverage neural circuits to restore immune homeostasis in diseases. By targeting central brain-body circuits that regulate systemic inflammation, Nilo offers a unique approach to immunomodulation, aiming to address a wide range of autoimmune and inflammatory diseases with significant unmet needs. The company is headquartered in New York, NY.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$101M
Total Amount Raised$101M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$101M
Latest Funding Amount$101M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Series A
$101.00M

Investors

Investor Name
Funding Round

Related News and Analysis